Drug Facts and Comparisons 2000: Pocket Version
This is the pocket version of 'Drugs fact and comparisons' (DFC), a loose-leaf drug information service published in the USA. This version is designed to provide an easy to use, concise, portable tool for daily practice at the point of care. Aimed at professionals, it gives information on over 600 generic drugs, with 2000 plus representative trade names. It is organised in twelve therapeutic categories to enable identification and comparison of similar agents. The categories are nutritionals, blood modifiers, hormones, cardiovasculars, respiratories, CNS drugs, gastrointestinals, anti-infectives, biologicals, topicals, antieoplastics and miscellaneous. Product tables which list trade names, methods of dosage, strengths and manufacturers are given at the beginning of each drug description. Actions, indications, contraindications, warnings, drug interactions and significant adverse reactions are also included.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
12 hours 24 hours absorption acid acute Administration and Dosage Adults Adverse Reactions agents amiodarone arrhythmias bioavailability breast milk calcium Capsules cardiac Children chronic clearance clinical Contraindications corticosteroids creatinine creatinine clearance daily dose decreased diarrhea didanosine digoxin discontinue disease diuretics divided doses Drug Interactions edema effects elderly erythromycin exceed excreted in breast ganciclovir half-life headache hepatic Hypersensitivity hypertension hypokalemia hypotension increased Indications infants infections infusion inhalations inhibit inhibitors initial dose Lactation levodopa liver maintenance metabolites metabolized metformin mg daily mg once daily mg Rx mg twice daily mg/5 ml mg/day mg/kg mg/kg/day mg/ml ml/min monitor nausea occur pain Parenteral Pharmacokinetics Pharmacology phenytoin potassium Pregnancy propafenone quinidine recommended dose reduce regimen renal function Renal function impairment renal impairment respiratory risk Safety and efficacy serum severe sodium sulfonylureas symptoms syndrome Tablets tachycardia theophylline therapeutic therapy tion toxicity treatment ulcer urinary urine usually Various ventricular vomiting weeks zidovudine